PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value
$23.51+0.17 (+0.73%)
Close on Nov 12, 2026Market cap $1.35BP/E –Yield –
PROCEPT BioRobotics r&d expenses
Research and development expenses are spending on new products and technology.
PROCEPT BioRobotics's R&D Expenses for the twelve months ending Sep 30, 2026 was $80.63M, up 19.8% year over year. For fiscal 2025 it was $71.28M, up 14.4% from the year before. The highest annual figure on record is $71.28M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.28M | +14.4% |
| FY2024 | Dec 31, 2024 | $62.30M | +28.6% |
| FY2023 | Dec 31, 2023 | $48.45M | +67.2% |
| FY2022 | Dec 31, 2022 | $28.98M | +52.6% |
| FY2021 | Dec 31, 2021 | $18.99M | +16.7% |
| FY2020 | Dec 31, 2020 | $16.28M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $20.01M | +10.0% |
| Q2 FY2026 | Jun 30, 2026 | $20.10M | +14.0% |
| Q1 FY2026 | Mar 31, 2026 | $21.47M | +30.9% |
| Q4 FY2025 | Dec 31, 2025 | $19.06M | +26.5% |
| Q3 FY2025 | Sep 30, 2025 | $18.19M | +9.3% |
| Q2 FY2025 | Jun 30, 2025 | $17.63M | +0.7% |
| Q1 FY2025 | Mar 31, 2025 | $16.40M | +25.4% |
| Q4 FY2024 | Dec 31, 2024 | $15.07M | +3.9% |
| Q3 FY2024 | Sep 30, 2024 | $16.65M | +43.5% |
| Q2 FY2024 | Jun 30, 2024 | $17.50M | +50.7% |
| Q1 FY2024 | Mar 31, 2024 | $13.08M | +21.9% |
| Q4 FY2023 | Dec 31, 2023 | $14.50M | +49.7% |
| Q3 FY2023 | Sep 30, 2023 | $11.60M | +53.0% |
| Q2 FY2023 | Jun 30, 2023 | $11.61M | +73.2% |
| Q1 FY2023 | Mar 31, 2023 | $10.74M | +114.3% |
| Q4 FY2022 | Dec 31, 2022 | $9.68M | +90.7% |
| Q3 FY2022 | Sep 30, 2022 | $7.58M | +54.1% |
| Q2 FY2022 | Jun 30, 2022 | $6.71M | +49.8% |
| Q1 FY2022 | Mar 31, 2022 | $5.01M | +10.8% |
| Q4 FY2021 | Dec 31, 2021 | $5.08M | +11.7% |
| Q3 FY2021 | Sep 30, 2021 | $4.92M | +26.4% |
| Q2 FY2021 | Jun 30, 2021 | $4.48M | – |
| Q1 FY2021 | Mar 31, 2021 | $4.52M | – |
| Q4 FY2020 | Dec 31, 2020 | $4.54M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.89M | – |
See a number that looks wrong?